PAC Dermatologia-1 Libro 1
Contenido
REFERENCIAS
  1. Pathak MA, Nghiem P, Fitzpatrick TB. Acute and Chronic Effects of the Sun in Dermatology in General Medicine, 5th ed, edited by TB Fitzpatrick et al; New York: McGraw Hill 1999, pp. 1598-1607.

  2. Gilchrest BA, Soter NA, Stoff JF, Mihm MC. The human sunburn reaction: histologic and biochemical studies. J AM Acad Dermatol 1981; 5, 4: 411-22.

  3. Meyers DP, Scott I, Lowe NJ. Exposure to low levels of ultraviolet light B or Ultraviolet light A induces cutaneous photodamage in human skin. Sunscreen: development, evaluation and regulatory aspects., 2nd ed, edited by NJ Lowe et al; New York, Marcel Dekker, Inc. 1997; 5: 101-115.

  4. Fisher GJ, Wang ZQ, Datta SC, Varani J, Kang S, Voorhees JJ. Pathophysiology of premature skin aging induced by ultraviolet light. N Engl J Med 1997, 337, 1419-28.

  5. Kricker A, et al. Sun exposure and non-melanocytic skin cancer. Cancer causes control, 1994; 5:367.

  6. Kriipke ML. Carcinogenesis: Ultraviolet Radiation in Dermatology in General Medicine, 5th ed, edited by TB Fitzpatrick et al; New York: McGraw Hill 1999, 465-72.

  7. Hawk JLM, Norris PG. Abnormal Responses to Ultraviolet Radiation: Idiopathic in Dermatology in General Medicine. 5th ed, edited by TB Fitzpatrick et al; New York, McGraw Hill 1999, pp. 1573-89.

  8. Ledo E. Photodermatosis. Part I: Photobiology, photoimmunology, and idiopathic photodermatoses. Int J Dermatol 1993; 32: 387-96.

  9. Hojyo-Tomoka T, Vega-Memije E, Granados J, et al. Actinic prurigo: An update. Int J Dermatol 1995; 34:380-4.

  10. Hojyo MT, Vega ME, Cortés R, et al. Prúrigo actínico como modelo de fotodermatosis crónica en Latinoamérica. Med Cutan Iber Lat Am 1996; 24:265-77.

  11. Moncada B, González-Amaro R, Baranda L, et al. Immunopathology of polymorphous light eruption. J Am Acad Dermatol 1994; 10:970-3.

  12. Guevara E, Hojyo-Tomoka MT, Vega-Memije ME. Estudio inmunohistoquímico para demostrar la presencia de linfocitos T y B en el infiltrado inflamatorio de las biopsias de piel, labio y conjuntiva de pacientes con prúrigo actínico. Dermatología Rev Mex 1997; 41: 223-6.

  13. Hojyo-Tomoka T, Granados J, Vargas-Alarcón G, et al. Further evidence of the role of HLA-DR4 in the genetic susceptibility to actinic prurigo. J Am Acad Dermatol 1997; 36: 935-7.

  14. Londoño F. Thalidomide in the treatment of actinic prurigo. Int J Dermatol 1973; 12:326-28.

  15. Saul A, Flores O, Novales J. Polymorphous light eruption: Treatment with thalidomide. Australas J Dermatol 1976; 17: 17-21.

  16. Epstein JH. Polymorphous light eruption. Dermatol Clin 1986; 4: 243-51.

  17. Norris PG, Hawk JLM. Polymorphic light eruption. Photodermatol Photoimmunol Photomed 1990; 7: 186-91.

  18. Van Praag MCG, Bom BW, Vermeer BJ. Diagnosis and treatment of polymorphous light eruption. Int J Dermatol 1994, 33: 233-9.

  19. Norris PG, Hawk JLM. Chronic actinic dermatitis: An unifying concept. Arch Dermatol 1990; 126: 376-8.

  20. Lim WH, Buchness MR, Ashinoff R, et al. Chronic Actinic Dermatitis. Study of the spectrum of chronic photosensitivity in 12 patients. Arch Dermatol 1990; 126: 317-23.

  21. Lim HW, Morison W, Kamide R, et al. Chronic actinic dermatitis: an analysis of 51 patients evaluated in the United States and Japan. Arch Dermatol 1944; 130: 1284 -9.

  22. Roelandts R. Chronic actinic dermatitis. J Am Dermatol 1993; 28: 240-9.

  23. Bruderer P, Shahabpour M, Chrisoffersen S, et al. Hydroa vacciniforme treated by a combination of beta-carotene and canthaxanthin. Dermatology 1995; 190: 343-5.

  24. Ketterer R, Morier P, Frenk E. Hydroa vacciniforme. Dermatology 1994; 189: 428-9.

  25. Ibarra-Durán G, Rodriguez-Jurado R, et al. Linfoma T cutáneo angiocéntrico en una niña con hidroa vacuniforme. Dermatologia Rev Mex 1991; 35(5): 344-48.

  26. Ruiz-Maldonado R, Millán-Parrilla F, Orozco-Covarrubias ML, et al. Edematouss scarring vasculitic panniculitis: A new multisystemic disease with malignant potential. J Am Acad Dermatol 1995; 32: 37-44.

  27. Ravits M, Armstrong R, Harber LC. Solar urticaria: clinical features and wavelength dependance. Arch Dermatol 1982; 118: 228-31.

  28. Horio T. Solar urticaria. In: Lim HW, Soter NA editors. Clinical Photomedicine, New York: Marcel Dekker, 1993: 181-92.

  29. Ryckaert S, Roelandts R. Solar urticaria: a report of 25 cases and difficulties iin phototesting. Arch Dermatol 1998; 134: 71-4.Ledo E. Photodermatoses Part II: Chemical photodermatoses and dermatoses that can be exacerbated, precipitated or provoked by light. Int J Dermatol 1993; 7: 480-92.

  30. Lim HW. Abnormal responses to ultraviolet radiation: Photosensitivity induced by exogenous agents in Dermatology in General Medicine, 5th ed, edited by TB Fitzpatrick et al; McGraw Hill 1999; 1589-98.

  31. Emmett EA. Phototoxicity from exogenous agents. Photochemistry and Photobiology 1979; 30: 439-46.

  32. Ledo E. Photodermatoses Part II: Chemical photodermatoses and dermatoses that can be exacerbated, precipitated or provoked by light. Int J Dermatol 1993; 7:480-92

  33. Kishwer N, Henry L. Phototoxicity and Photoallergy. Dermatol Nurs 1995; 7: 227-36.

  34. DeLeo VA. Photoallergy. In: Lim HW, Soter NA, editors. Clinical photomedicine. New York: Marcel Dekker, 1993: 227-39.

  35. Thiers BH. The porphyrias. J Am Acad Dermatol 1981; 5 (5): 621-25.

  36. De Castro M, et al. Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda. Hepathology. 1993; 17 (4): 551-7.

  37. Hift RJ, et al. Hepatoerythropoietic porphyria precipitated by viral hepatitis. Gut. 1993; 34 (11): 1632-4.

  38. Bickers DR, Pathak MA, Lim HW. The porphirias. In Dermatology in General Medicine 5th ed, edited by TB Fitzpatrick et al; New York, Mc Graw Hill 1999, 1766-1803.

  39. Buchness MR: Photoexacerbated dermatoses. In: Lim HW, Soter Na, editors. Clinical photomedicine. New York: Marcel Dekker, 1993 269-85.

  40. Bennion SD, Norris DA. Ultraviolet light modulation of autoantigens, epidermal cytokines and adhesion molecules as contributing factors of the pathogenesis of cutaneous LE. Lupus 1997; 6:181.

  41. Lehman P, et al. Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation. J Am Acad Dermatol, 1990; 22: 181.

  42. Norris DA. Pathomechanisms of photosensitive lupus erythematosus. J Invest Dermatol 1993; 100:588.

  43. Cram DL, et al. Ultraviolet induced acantholysis in familiar benign chronic pemphigus. Arch Dermatol 1967; 96: 636.

  44. Burge SM: Hailey-Hailey disease: the clinical features, response to treatment and prognosis. Br J Dermatol 1992;126(3):275-82.

  45. Ayres S Jr, et al. Keratosis follicularis. Arch Dermatol 1972; 106: 909.

  46. Baba T, et al. UV radiation and keratosis follicularis. Arch Dermatol 1984; 120: 1484.

  47. Kraemer KH, et al. Xeroderma pigmentosum: cutaneous, ocular and neurologic abnormalities in 830 published cases. Arch Dermatol 1987; 123: 241-50.

  48. Kondo S, Fukoro S, Nishioka K, et al. Xeroderma pigmentosum: recent clinical and photobiological aspects in 830 published cases. Arch Dermatol. 1987;123:241-50.

  49. Gretzula JC, Oscar Hevia BS, Weber PJ. Bloom´s syndrome. J Am Acad Dermatol 1987; 17: 479.

  50. Moss C. Rothmund-Thompson syndrome: a report of two patients and a review of the literature. Br J Dermatol 1990;122:821.

  51. Levy H. Hartnup Disorders in the Metabolic Basis of Inherited Disease, 6th ed, New York, McGraw Hill, 1989; 2515.

  52. Wheeler CE Jr, Hill C. The herpes simplex problem. Aj Am Acad Dermatol 1988; 18: 163-68.

  53. Perna JJ, Mannix ML, Rooner JF. Reactivation of latent herpes simplex virus infection by ultraviolet light: A human model. J Am Acad Dermatol 1987; 17: 473-78.

  54. Rocley PF, Tyring SK. Pathophysiology and clinical manifestations of varicella zoster virus infections. Int J Dermatol 1994;33:227-32.

  55. Arenas R. Dermatología: Atlas, diagnóstico y tratamiento. 2ª ed, McGraw Hill, 1996; 404-6.

  56. Bourges H. La pelagra y la niacina. Cuadernos de nutrición, IV. 1984; 7 (1): 3-10.

  57. Jukes TH. Conquest of Pellagra. Federation Proceedings, 1981; 40 (5): 1519-37.

  58. Stratigos JD, et al. Pellagra a still existing disease? B J Dermatol. 1977; 96 (1): 99-106.

  59. Grover RW. Transient acantholytic dermatosis. Arch Dermatol 1970; 101: 426.

  60. Shumack SP, Commens CA. Disseminated superficial actinic porokeratosis: a clinical study. J Am Acad Dermatol 1989; 20: 1015.

  61. El-Zawahry M. Lichen planus tropicus. Dermatol Int 1965; 4: 92.

  62. Salman SM, et al. Actinic lichen planus: Clinicopathologic study of 16 patients. J Am Acad Dermatol 1989; 20: 226.

  63. Van der Schroeff JG, et al. Induction of actinic lichen planus with artificial UV sources. Arch Dermatol 1983; 119: 498.

  64. Diette KM, et al. Role of ultraviolet A therapy for psoriasis. J Am Acad Dermatol 1984; 11: 441.

  65. Kligman AM, et al. Rosacea. Dermatology 1978; 1: 27.

  66. Bleicher PA, et al. Topical metronidazole therapy for rosacea. Arch Dermatol 1987; 123: 609.

  67. Schmidt JB, et al. Rosacea. Int J Dermatol 1983; 22: 393.

  68. Sánchez NP, Pathak MA, Sato S, et al. Melasma: A clinical, light microscopic, ultrastructural, and immunofluorescence study. J Am Acad Dermatol 1981; 4: 698.

  69. Piquero-Martín J. Melasma in Central and South America. Clin Drug Invest 1995; 10 (Suppl 2): 41.

  70. Grimes PE. Melasma. Etiologic and therapeutic considerations. Arch Dermatol 1995; 131: 1453-57.

  71. Saeb-Lima M, et al. Principales Fotodermatosis en Latinoamérica: Revisión y Actualización. Dermatol Venez 1999; 37: 15-21.

  72. Domínguez Soto L, Hojyo-Tomoka MT, et al. Photodermatoses in Tropical Countries. Clinics in Dermatology 1999; 17: 237.

  73. Thompson SC, Jolley D, Marks B. Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993; 329: 1147-1151.

  74. Boyd AS, Naylor M, Cameron GS et al. The effects of chronic sunscreen use on the histologic changes of dermatoheliosis. J Am Acad Dermatol 1995; 33: 941-946.

  75. Urbach F. Ultraviolet A transmission by modern sunscreens: is there a real risk? Photodermatol Photoimmunol Photomed 1992/1993; 9: 237-241.

  76. Ying CY, Parish JA, Pathak MA et al. Additive erythemogenic effects of middle (280-320 nm) and longwave (320-400 nm) ultraviolet light. J Invest Dermatol 1974; 63: 273-278.

  77. Sternborg HJCM, van der Leun JC. Tumorigenesis by a long wavelength UVA source. Photochem Photobiol 1990; 51: 325-330.

  78. Lavker RM, Gerberick GF, Veres D, et al. Cumulative effects from repeated exposures to suberythemal doses of UVB and UVA in human skin. J Am Acad Dermatol 1995; 32: 53-62.

  79. Lowe NJ, Meyers DP, Wieder JM, et al. Low doses of repetitive ulttraviolet A include morphologic changes in human skin. J Invest Dermatol 1995; 105: 739-743.

  80. Kligman LH. Intensification of ultraviolet-induced dermal damage by infrared radiation. Arch Dermatol Res 1982; 272: 229-238.

  81. Pujol JA, Lecha M. Photoprotection in the infrared radiation range. Photodermatol Photoimmunol Photomed 1992/1993; 9: 275-278.

  82. Sayre RM, Kollias N, Roberts RL, et al. Physical sunscreens. J Soc Cosmet Chem 1990; 41: 103-109.

  83. Roelandts R. Which components in broad-spectrum sunscreens are most necesary for adequate UVA protection? J Am Acad Dermatol 1991; 25: 999-1004.

  84. Foley P, Nixon R, Marks R, et al. The frequency of reactions to sunscreens: results of a longitudinal population-based study on the regular use of sunscreens in Australia. Br J Dermatol 1993: 128: 512-518.

  85. Szczurko C, Dompmartin A, Michel M et al. Photocontact allergy to oxybenzone: ten years of experience. Photodermatol Photoimmunol Photomed 1994; 10: 144-47.

  86. Bech-Thomsen N, Wulf HC. Sunbathers’ application of sunscreen is probably inadequate to obtain the sun protection factor assigned to the preparation. Photodermatol Photoimmunol Photomed 1992-1993; 9: 242-244.

  87. Levy SB. Sunscreens for photoprotection. Dermatol Ther 1997; 4: 59-71.

  88. Lyde CB, Bergstresser PR. Ultraviolet protection from sun avoidance. Dermatol Ther 1997; 4: 72-78.

  89. McLean DI, Gallagher R. Sunscreens: use and misuse. Dermatol Clin 1998; 219-26.
Contenido
Copyright © 2000 Dr. Scope. Derechos Reservados.
Diseño y Programación: Educación Médica Contínua